Clinical Trial Update: Dose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 dose-escalation and safety study of birinapant (TL32711) in patients with advanced or metastatic solid tumors, including safety data for combination c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Birinapant

Snippet

Sponsor: TetraLogic Pharmaceuticals | Conditions: Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-05-30